- Home
- MGRX vs SNES Comparison
MGRX vs SNES Comparison
Compare MGRX & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- SNES
- Stock Information
- Founded
- MGRX 2021
- SNES 2004
- Country
- MGRX United States
- SNES United States
- Employees
- MGRX N/A
- SNES N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- SNES Agricultural Chemicals
- Sector
- MGRX Technology
- SNES Industrials
- Exchange
- MGRX Nasdaq
- SNES Nasdaq
- Market Cap
- MGRX 23.3M
- SNES 24.0M
- IPO Year
- MGRX 2023
- SNES 2016
- Fundamental
- Price
- MGRX $2.45
- SNES $4.13
- Analyst Decision
- MGRX
- SNES Strong Buy
- Analyst Count
- MGRX 0
- SNES 1
- Target Price
- MGRX N/A
- SNES $10.00
- AVG Volume (30 Days)
- MGRX 177.2K
- SNES 138.8K
- Earning Date
- MGRX 11-13-2025
- SNES 11-11-2025
- Dividend Yield
- MGRX N/A
- SNES N/A
- EPS Growth
- MGRX N/A
- SNES N/A
- EPS
- MGRX N/A
- SNES N/A
- Revenue
- MGRX $516,030.00
- SNES $2,093,000.00
- Revenue This Year
- MGRX N/A
- SNES $49.17
- Revenue Next Year
- MGRX N/A
- SNES $89.89
- P/E Ratio
- MGRX N/A
- SNES N/A
- Revenue Growth
- MGRX N/A
- SNES 36.89
- 52 Week Low
- MGRX $1.32
- SNES $1.30
- 52 Week High
- MGRX $6.15
- SNES $6.24
- Technical
- Relative Strength Index (RSI)
- MGRX 58.43
- SNES 43.60
- Support Level
- MGRX $2.04
- SNES $3.74
- Resistance Level
- MGRX $2.66
- SNES $4.76
- Average True Range (ATR)
- MGRX 0.26
- SNES 0.32
- MACD
- MGRX 0.01
- SNES -0.07
- Stochastic Oscillator
- MGRX 71.19
- SNES 35.14
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.